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Delayed type hypersensitivity (DTH) reactions are considered infrequent complications in
arthroplasty, but have been recognized to be associated with devastating morbidity and
substantial decrease in quality of life of affected patients. Chronic inflammation of artificial
joints and associated loss of peri-implant bone often require revision surgery. Methods
for the diagnosis of implant-related DTH are available but infrequently considered to the
full extent. Sequential diagnostics based on exclusion of septic complications, local and
systemic metal level determination, lymphocyte transformation testing (LTT), and local
T cell subset analysis are required for an unequivocal DTH diagnosis. Here, we report
on a patient with a history of chronic rheumatoid arthritis and an unfavorable outcome
of unilateral knee arthroplasty. This case illustrates pitfalls and difficulties in the course
of recurrent inflammation following joint replacement. In the early course, suspicion of
low-grade bacterial infection led to three two-stage revisions. Afterwards, the joint was
proven to be sterile. However, metal level quantification revealed release of especially
cobalt and chromium from the joint, LTT indicated persisting cobalt and nickel
sensitization and subset analysis of T cells from the synovium suggested DTH as a root
cause for the inflammatory symptoms. This report aims to recommend the depicted
diagnostic algorithm as an adequate tool for future DTH detection. Yet, systemic to local
subset ratios for effector memory and regulatory T cells should be derived from sufficient
patient numbers to establish it as a diagnostic marker. Moreover, future prospects
regarding implant-related DTH diagnostics are discussed. Therapeutic options for
the portrayed patient are proposed, considering pharmaceutical, cell-therapeutic and
surgical aspects. Patients who experience peri-implant inflammation but do not have
obvious mechanical or infectious problems remain a diagnostic challenge and are
at high risk of being treated inadequately. Since potentially sensitizing materials are
regularly used in arthroplasty, it is essential to detect cases of acute DTH-derived
inflammation of an artificial joint at early postoperative stages. This would reduce the
severity of inflammation-related long-term consequences for affected patients and may
avoid unnecessary revision surgery.
Keywords: delayed type hypersensitivity, arthroplasty, lymphocyte transformation test, T cell subsets, allergy
diagnostics
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INTRODUCTION
Arthroplasty is a successful and nowadays essential surgery.
In patients suffering from end-stage joint destruction due to
osteoarthritis or secondary to rheumatoid arthritis (RA) or other
conditions, it significantly improves quality of life by reducing
pain, restoring function, and increasing physical activity. Rather
infrequently, metals released from implant materials cause local
and systemic complications (1).
Peri-implant osteolysis is a highly prevalent non-infectious
local complication and known to be driven by chronic innate
immune responses to wear particles, whereas the pathogenesis
of rarely occurring acute or chronic inflammation due to
delayed type hypersensitivity (DTH) is mediated by an adaptive
immune response (2). In early-onset osteolysis both processes are
described to be tightly intertwined (3). Classical symptoms of
an acute periprosthetic joint inflammation are most commonly
related to bacteria induced periprosthetic joint infection (PJI).
However, after microbiological exclusion of septic complications,
the differential diagnosis of sterile metal-related hypersensitivity
remains conceivable (4). Multiple factors influence the outcome
of the inflammatory processes and their biological consequences,
such as elemental composition and chemical speciation of wear
debris, exposure level and exposure duration as well as the
local environment (5, 6). Materials used in arthroplasty hold the
potential to induce DTH reactions. In particular, metals such as
nickel, cobalt and chromium are attributed to DTH (7), whereas
the chemical speciation and protein interaction of these metals
determine their immunogenicity (8, 9). Metal ions and particles
released due to corrosion processes are linked to adaptive
immune responses in arthroplasty (10). Titanium-, cobalt- and
chromium-containing particles were detected in periprosthetic
compartments with cobalt and chromium present in the non-
particulate/ionic state (11). Beside metal ions, other compounds
used in arthroplasty like initiators of the polymerization of
methyl methacrylate (bone cement) are known sensitizers (12).
Antibiotic additives of bone cement are also known to have
sensitization capacity (13).
Metal ions and other sensitizing compounds have the
potential to bind self-peptides or self-proteins and form haptens
(14). In cutaneous and drug-associated DTH these haptens can
act as antigens and, upon subsequent exposure, cause clonal
expansion of specific effector memory T cells and clinical
manifestation of acute inflammation. Comparable mechanisms,
characterized by perivascular lymphocytic infiltrate, have been
identified in the peri-implant membrane (15). DTH reactions
beyond the peri-implant membrane in the adjacent bone marrow
are currently proposed and discussed (16).
Generally, local hypersensitivity reactions to orthopedic
implants are difficult to diagnose, mainly because of considerable
individuality of patients’ inflammation and associated
characteristics as well as due to close similarities with PJI
in clinical presentation. Sterile toxicity induced hypersensitivity
reactions and other reasons for joint inflammation like RA
additionally hinder the recognition of DTH based on clinical
examination. Reliable diagnostic tools and algorithms are
urgently needed to ensure the diagnosis of implant-related DTH.
This report illustrates a possible step-wise diagnostic work-up
for cases of suspected peri-implant hypersensitivity.
CASE PRESENTATION
We report the case of a 71-year-old female patient with chronic
RA who presented at our institution 4 years after right-sided
re-re-revision total knee arthroplasty with debilitating chronic
pain, swelling, and severely itchy eczema (2014/03–2018/03)
(Figure 1). This patient has a complex medical and orthopedic
history (Supplementary Table 1). She was diagnosed with
seropositive RA in 1969. As this chronic inflammatory, joint
damaging disease progressed she underwent therapy with
different disease-modifying anti-rheumatic drugs, extensive
physiotherapy and eventually several surgical procedures
addressing her initially dominating right-sided hand and wrist
pain. Since 2005, the patient had been suffering from progressive
bilateral knee pain, culminating in near immobilization in 2009.
Considering clear right-sided domination of clinical complaints,
functional deficit and radiographic lesions characteristic for RA-
induced joint destruction, she underwent right-sided cemented
primary total knee arthroplasty in 2009/05. Both intra- and
short-term postoperative courses were uneventful. At routine
follow-up 6 months postoperatively, the patient showed excellent
joint function and overall mobilization, minimal swelling, a
non-irritated surgical scar and denied relevant pain of the
right knee.
However, 33 months after primary implantation (2012/02),
the patient presented at our institution with right-sided knee
pain, moderate local swelling, local hyperthermia, distinct itchy
eczema scattered across the right leg and involving the surgical
scar. She reported a progression of those symptoms over the
previous 12 months. Ad interim, she had received steroid
injections from her treating rheumatologist twice, both of which
alleviated her complaints for about 10 weeks. However, in
the course of that consultation, routine blood tests and knee
joint aspiration were performed to rule out infection. Blood
leukocyte count was normal, CRP was 37 mg/l (Ref., <5
mg/l) and synovial leukocyte count was 352/µl. Aspiration had
not yielded sufficient volume to run microbiological cultures.
Further, standard radiographs revealed loosening of the tibial
component. Considering that the patient had a history of Lichen
ruber, involving predominantly the trunk and her lower legs,
dermatologists were consulted to evaluate the skin lesions,
and judged them as pruritic dermatosis not associated to
Lichen ruber.
The synopsis of findings led to the suspicion of a low-grade PJI
and thus to two-stage revision arthroplasty (2012/04, 2012/07).
Here, bone cement without antibiotic additive was used due to
the patient’s report of a previous allergic reaction to gentamicin.
Histopathological examination of tissue samples taken during
explanation of the primary implant and implantation of
the secondary implant endorsed a wear particle induced
type periprosthetic membrane and a low-grade infection,
respectively. Microbiological analysis of cultures of synovial fluid,
periprosthetic tissue and sonication fluid revealed no significant
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FIGURE 1 | Sequential anteroposterior radiographs of the patient’s right knee indicate progression of bone loss and photographs of the right leg show persisting
eczema. (A) Radiography prior to primary knee replacement depicts joint degeneration secondary to rheumatoid arthritis, 2009/03. (B) Pre-revisional radiograph
indicates peri-implant bone loss and loosening of the tibial component, 2012/03. (C) Post-revisional radiograph depicts intense intraoperative usage of cement and
progressive bone loss, 2012/07. (D) Radiographic status at the time of hypersensitivity diagnostics, 03/2018. (E) Latest radiographic status (patient in supine
position), 01/2019. (F) Eczema at the time of hypersensitivity diagnostics, 03/2018. (G) Follow-up examination in the aftermath of rituximab therapy indicated an
unimproved cutaneous status, 03/2019.
growth. However, the patient underwent empiric antibiotic
therapy. Yet, the postoperative course was characterized by
persistent pain and swelling, and eczema progression. Due to
suspicion of persisting PJI, she underwent further arthrocenteses
in 2012/09 and 2013/08, both of which showed no significant
microbial growth. Of note, the femoral component of the
secondary endoprosthesis implanted after temporary arthrodesis
in 2012/07 was composed of cobalt-chromium-molybdenum
(CoCrMo) and high nitrogen stainless steel with a nickel content
of approximately 10% (Supplementary Table 2).
Since the patient’s complaints aggravated further she sought
a second opinion at a different hospital. There, the secondary
implant was revised in 2014/02, following microbial detection
of multi-resistant Staphylococcus epidermidis (according to the
discharge letter; the respective microbiology report was not
available). In the consecutive year, she underwent another two-
stage revision due to suspected persistent low-grade infection
of the right knee (2015/06, 2015/08). However, there was no
documentation of relevant microbial growth and histopathology
revealed a type 3 periprosthetic membrane (i.e., a combination
of a wear and an infection induced histology pattern) (17). As in
the primary and the secondary implants, both, tibial, and femoral
components of the tertiary and of the quaternary implants
contained the CoCrMo alloy (Supplementary Table 2). After the
third revision arthroplasty, the patient’s complaints improved
moderately for roughly 8 weeks before deteriorating to the
maximum of reported pain, skin irritation, and immobilization
in 2018. Then, she was referred to us by rheumatologists to
rule out PJI of the right knee again. At that consultation, the
patient reported that she had been diagnosed with cobalt allergy
through skin patch testing in 2015. Considering the patient’s
progressive eczema surrounding and including her arthroplasty
scars, the dermatologists’ judgement of that not being associated
with the pre-existent Lichen ruber, and the patient’s report of
metal allergy, acute inflammation due to implant-related metal
hypersensitivity seemed more probable.
Therefore, we sampled periprosthetic fluid via percutaneous
arthrocentesis for microbiological, pathological, and cytological
examinations. Furthermore, multi-element analyses of synovial
fluid and whole blood were performed to investigate relevant
metal quantities. Serum and whole blood of the patient were
obtained for a lymphocyte transformation test (LTT), which
includes exposure to all potentially sensitizing metals and
substances used in joint arthroplasty. The cellular composition
of whole blood and synovial fluid were analyzed with flow
cytometry and specific focus on T cells and its subsets. The
findings of those tests are presented and discussed below.
Of note, in 2019/01 the patient presented at the department of
rheumatology of our institution where she underwent inpatient
rituximab therapy and multimodal RA staging. Again, systemic
infection-indicating parameters (CRP, leukocytes) were within
reference levels and analysis of the right knee’s synovial fluid did
not indicate infection. At the time of the most recent orthopedic
follow-up examination (2019/03), recovery had not been reached.
The patient’s medical and implant data including information
on manufacturers, compositions and fixation methods
Frontiers in Immunology | www.frontiersin.org 3 November 2019 | Volume 10 | Article 2758
Schoon et al. Metal Hypersensitivity in Arthroplasty
of the knee arthroplasty implants are concisely listed in
Supplementary Tables 1, 2.
MULTI-STAGE DIAGNOSTICS
Routine blood tests showed non-elevated systemic levels of
CRP (4.8 mg/l; Ref., < 5 mg/l) and leukocytes (6.7/nl; Ref.,
3.9/nl−10.5/nl). Flow cytometry analysis of the peri-implant
synovial fluid sampled by percutaneous arthrocentesis revealed a
leukocyte count of 1,105/µl; 36.2% of total leukocytes were found
to be mononuclear cells and 63.8% polymorphonuclear (PMN)
cells. In accordance with clinical guideline, leukocyte numbers
of >2,000/µl and the presence of >70% PMNs of the leukocytes
would match the criteria for PJI (18). The examination of the
periprosthetic joint fluid by a surgical pathologist revealed a
low cell content and no signs of infection which is indicative
for the absence of a bacterial high-grade infection. Moreover,
no gout or pseudogout crystals were found. In summary,
cytological and pathological examinations proved no evidence
for bacterial infection. However, results from microbiological
examination were pending at the time of the above
mentioned diagnostics.
LTT was performed as previously shown (19), with
modifications toward endoprostheses-relevant allergens. It
revealed a moderate cellular sensitization in the sense of a DTH
reaction to nickel by a stimulation index of 4.6 and marginally
to cobalt by a stimulation index of 2.9, indicating circulating
allergen specific T cells (Figure 2A). There were no significant
signs of sensitization following exposure to any other tested
relevant metals, cement monomers or antibiotics. The used salts
and compounds are depicted in Supplementary Table 3.
Bloodmulti-element analysis with inductively coupled plasma
mass spectrometry (ICP-MS) showed moderately, yet increased
systemic cobalt (2.10 µg/l) and chromium (0.94 µg/l) levels
(Table 1). With 44.2 µg/l cobalt and 12.7 µg/l chromium
in the peri-implant synovial fluid, local metal levels clearly
surpassed systemic ones. Thus, metal level quantification hinted
at the potential of released cobalt and chromium to promote
inflammatory symptoms, whereas a contribution of cobalt can
be confirmed considering the LTT and the previously performed
patch test.
Fluorescence-activated flow cytometry analysis of T cell
subsets showed 13.1% CD3+ T cells in the peri-implant synovial
fluid within the total population of CD45+ cells, the majority
of T cells being effector memory T cells (Table 2). In particular,
66.5% of all CD4+ and 51.2% of all CD8+ T cells belonged to
the effector memory compartment, which represents an 8-fold
increase in CD4+ T cells and a 4-fold increase in CD8+ T cells
when compared to peripheral blood levels (Figure 2B). Up to
31.2% of the CD4+T cell population were shown to be regulatory
T cells, which is an 8-fold increase vs. circulating T cell numbers
(Table 1). In summary, flow cytometry analysis identified local
invasion or expansion of effector memory and regulatory T cells.
This is typical for DTH and pathogen induced immune reactions.
However, microbiological examination displayed no signs of
bacterial growth following aerobic and anaerobic incubation
for seven and 14 days, respectively. Therefore, a bacterial peri-
prosthetic infection as underlying reason for the inflammatory
symptoms was excluded.
Except for the T cell subset analysis with flow cytometry,
the presented methods were in line with standard diagnostic
methods that are routinely performed by accredited medical
testing laboratories and therefore readily available for most
hospitals in industrialized countries. Flow cytometry analysis of
T cell subsets was performed by commercially available dry pre-
formulated antibody panels (DURAClone, Beckman Coulter) as
previously shown for blood samples (20).
DISCUSSION
We report the case of a patient with a long-standing
history of RA who has been suffering from chronic pain
syndrome following right-sided total knee arthroplasty for
many years. Generally, RA is not considered to be a risk
factor for poor patient reported outcome in knee arthroplasty
(21). Yet, on suspicion of bacterial low-grade infection the
reported patient’s artificial knee joint had been revised three
times. At the time of performance of the majority of the
diagnostic tests, the painful knee joint was found to be
sterile. Since primary implantation the patient has suffered
severe bone loss surrounding the implant. Despite previously
diagnosed hypersensitivity to cobalt by patch testing, a CoCrMo
containing implant was used in the course of the latest revision
surgery. Summing up the results of the performed multi-
stage diagnostics, we conclude that the patient’s symptoms are
most likely associated to aseptic peri-implant inflammation
due to metal release from the artificial joint and cobalt
hypersensitivity. Whether cutaneous alterations of the lower
extremities are hypersensitivity-induced cannot be answered
by the performed diagnostics. Following the expertise of
the involved dermatologists the eczema was most likely a
pruritic dermatosis not associated to pre-existent autoimmune
Lichen ruber. Considering its onset after primary TKA, metal
hypersensitivity represents a potential trigger.
The patient suffers from concomitant rheumatic disease,
which is known to show abundant numbers of effector
T cells in the synovium (22). It cannot be excluded that
these local cells derive from her rheumatoid comorbidity.
At the time of DTH diagnostics, the patient’s rheumatic
disease was not treated pharmacologically. However, 9 months
after hypersensitivity diagnostics, she underwent inpatient
immunosuppressive therapy with rituximab in the course of
the treatment of chronic rheumatoid polyarthritis (elsewhere).
This treatment was indicated, since there were no signs of
local bacterial infection and previous treatment with rituximab
was well-tolerated.
Rituximab acts as a B cell depleting agent. Follow-up clinical
examination after 10 weeks of inpatient therapy showed that
the symptomatology of the aseptic peri-implant inflammation
and cutaneous alterations had not significantly improved. The
acute inflammatory phase of DTH is known to be initially
driven by clonal expansion of effector T cells. Yet, in the
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FIGURE 2 | Lymphocyte transformation test (LTT) and T cell subsets analyses point toward T cell mediated hypersensitivity as the root cause for local inflammation.
(A) Exposure to various arthroplasty-relevant noxae revealed increased T cell proliferation following cobalt and nickel exposure. Mean stimulation index (proliferation
with antigen divided by proliferation without antigen) values (n = 3) of >2 indicate marginal sensitization and values >3 can be considered positive. (B) Scatter dot
plots of circulating T helper cells (CD4+) and cytotoxic T cells (CD8+) indicate abundance of effector memory T cells in the synovium of the affected knee. MMA,
methyl methacrylate; N,N-D4T, N,N-dimethyl-p-toluidine; BPQ, benzoyl peroxide; HQ, hydroquinone; GM, gentamicin.
TABLE 1 | Systemic and local metal levels [µg/l] analyzed with inductively coupled plasma mass spectrometry.
Co Cr Mo Ni Ti Al Nb V Zr
Whole blood at
presentation
2.1 (+) 0.94 (+) 0.7 0.5 14.9 <10.0 <2.0 <0.20 <2.0
Whole blood at
follow-up




<1.21 0.14–0.52 0.3–1.3 <3.8 <16.1 <11.4 <2.0 <0.20 <2.0
Synovial fluid at
presentation
44.2 12.7 1.8 <1.0 6.3 <20 <0.20 0.20 <1.0
+, increased; *, reference values were established by metal level quantification in >6,000 individual blood samples; limits of quantification are reported in Supplementary Table 4.
course of RA treatment classical methotrexate therapy, which
would additionally target T cell activation and T cell receptor
expression, had not been appropriate due to the patient’s reported
methotrexate intolerance. Leflunomide or a combination of
leflunomide with TNF inhibitors could be considered as
potential treatment for patients with RA. In a case of non-
DTH induced implant-related inflammatory arthritis, long-
term prednisolone and leflunomide therapy were reported to
control the symptoms (23). In the presented case, however, the
eczema of the lower extremity worsened despite three months
of leflunomide monotherapie. Other immunosuppressive, cell-
therapeutic and surgical treatment options must be discussed.
In terms of immunosuppressive therapy, a major aim would be
targeting both, RA and metal hypersensitivity. Another option
for pharmaceutical treatment targeting the suppression of T
cell immunity are calcineurin inhibitors like cyclosporine. This
drug is known for successful prevention of transplant rejection;
another T cell mediated reaction, closely resembling a DTH
reaction. Cyclosporine in combination with TNF inhibitors is
administered for RA treatment in hepatitis C virus positive
patients (24). In the future, a regulatory T cell-mediated cell
therapy as currently used in the prevention of transplant rejection
may be advised (25). In terms of surgical intervention, treatment
options are not as diverse. Due to chronic inflammation of
the artificial joint, the patient is at risk of further bone loss
and decreased bone quality. CoCrMo-free knee endoprostheses
large enough for treatment of such advanced bone loss, e.g.
CoCrMo-free tumor prostheses, are currently not available on
the market. Arthrodesis must be considered, as it may be
performed without the use of CoCrMo-containing components
and may allow for extremity salvage. However, surgical options
are critically limited not only by the apparent intolerance tometal
implant components and the patient’s allergic predisposition
but also by the actual gap between remaining bones. In fact,
operative tracks to achieve symptom relief and retain function
are nearly exhausted. To “surgically terminate” metal exposure,
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TABLE 2 | Systemic and local T cell subsets.
T cell basic subsets
Marker CD45+ CD3+ CD4+ CD8+
Gate Singlets CD45+ CD3+ CD3+
Subset Leukocytes T cells Th cells Tc cells
Blood [% gate] 65.7 20.6 83.1 14.9
Synovial fluid [% gate] 50.6 13.1 66.6 24.3
Fold change [local/systemic] 0.8 0.6 0.8 1.6
Th subsets
Marker CCR7+/CD45RA+ CCR7-/CD45RA- CCR7-/CD45RA+
Gate CD4+ CD4+ CD4+
Subset Naïve Effector memory TEMRA
Blood [% gate] 39.3 8.2 n < 50
Synovial fluid [% gate] 2.6 66.5 n < 50
Fold change [local/systemic] 0.1 8.1 —
Tc subsets
Marker CCR7+/CD45RA+ CCR7-/CD45RA- CCR7-/CD45RA+
Gate CD8+ CD8+ CD8+
Subset Naïve Effector memory TEMRA
Blood [% gate] 45.5 12.5 25.0
Synovial fluid [% gate] 17.5 51.2 5.0
Fold change [local/systemic] 0.4 4.1 0.2
Treg subsets
Marker CD25+/CD45RA+ CD25+/CD127- CD25+/FoxP3+
Gate CD4+ CD4+ CD4+
Subset Naïve Treg Treg
Blood [% gate] n < 50 4.1 4.5
Synovial fluid [% gate] n < 50 31.2 21.6
Fold change [local/systemic] — 7.8 4.8
the associated local inflammation and further local and systemic
adverse effects, ultima ratio would be amputation.
Facing the depicted drastic course of routine joint
replacement vigorously illustrates the need for advanced
metal hypersensitivity diagnostics and their integration into
clinical decision making. Recently, another diagnostic algorithm
related to the one suggested in this report, has been proposed
(26). An important part of that algorithm is the initial exclusion
of PJI and mechanical complications. Diagnostic tools to rule out
PJI more rapidly than microbiological examination are currently
under development (27). Furthermore, systemic and local metal
levels should be quantified to evaluate metal release potentially
inducing DTH reactions and inflammation. This analysis should
include all relevant elements contained in the individual implant
set-up. Subsequent examination of putative DTH is important,
in particular before revision surgery. The two options currently
available to diagnose DTH comprise the patch test for contact
allergy and LTT. In arthroplasty, the prognostic and diagnostic
value of these methods is called into question on the basis of
controversial results of clinical studies (28). One reason for
inconclusive results could be that the systemic immune status
does not sufficiently reflect the periprosthetic immune cell
composition (16). It is also possible that the spectrum of locally
released potential allergens in terms of physicochemical diversity
is more distinct than displayable in the LTT by soluble salts. To
improve future DTH diagnostics, we envision to extend the LTT
by stimulation with endogenously generated haptens and by T
cell analysis of the synovial fluid (e.g., by flow cytometry).
Further characterization of local T cell subsets would be of
value to strengthen LTT results. In particular, modern methods
for analyzing the T cell receptor repertoire could help detect
clonal expansion of effector memory T cells (29). Secondly, we
envision to optimize the LTT by using cell depleted artificial
joint aspirates as antigen cocktails comprising the endogenously
produced haptens of the individual patient. The latter measure
is aimed to mimic closely endogenous conditions in DTH
inflamed joints. These changes and additions to the current LTT
protocol may yield a diagnostic tool of superior sensitivity, still
excluding the risk of iatrogenic sensitization inferred by the patch
test. Future studies evaluating these diagnostic innovations may
help to trace potential links between locally present allergens
and known metalorganic compounds, breaking new ground in
the development of novel biomarkers for DTH. This could be
accomplished through methods readily used in proteomics.
It is of uttermost importance to establish suitable thresholds
for specific T cell subpopulations in synovial fluid and other local
compartments, to perform local T cell analyses in cohorts of
sufficient sample size and to finally combine those with systemic
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and local metal exposure determination and advanced LTT.
This proceeding may be useful to back the clinical diagnosis of
implant-related hypersensitivity in the future. An ideal diagnostic
tool for DTH in arthroplasty must not be influenced in sensitivity
and specificity by concomitant infection or any other reason for
joint inflammation.
CONCLUDING REMARKS
This case demonstrates the importance of a thorough diagnostic
work-up and suggests an algorithm for consecutive testing
of patients with indications or merely anecdotal evidence of
DTH to their implant material. This algorithm consists of
exclusion of PJI, local and systemic metal level quantification,
an LTT specific for metals and organic substances used in
arthroplasty and local and systemic T cell subset analyses.
Additionally, we recommend establishing thresholds for defining
clinically relevant quantities of effector memory T cell and
regulatory T cell fractions. This could help to derive unequivocal
diagnosis of implant-related hypersensitivity and to facilitate
the identification of therapeutic needs of patients suffering
from aseptic periprosthetic inflammation in the aftermath of
joint replacement surgery. Even though hypersensitivity is rare,
patients scheduled to undergo primary arthroplasty should be
informed about severe and possibly devastating consequences
including loss of ambulation, amputation, and severe systemic
adverse events.
The presented complex case underlines that the diagnosis
of hypersensitivity to wear and corrosion products from
endoprostheses can currently not be substantiated but only
be considered after the exclusion of septic complications. In
summary, there is a distinct clinical need for specific implant-
related hypersensitivity diagnostics. Close collaboration between
clinicians, toxicologists, immunologists, and routine medical
laboratories is required.
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